vaccine

AstraZeneca and Johnson & Johnson announced Friday that they would resume their phase 3 clinical trials on COVID-19 vaccine candidates in the U.S, NBC News reports.

These are the links we promised to share on News4.

The director of Operation Warp Speed says a COVID-19 vaccine could be ready for review as early as November. News4’s Cory Smith explains what it will take to get a safe and effective vaccine across the finish line.

AstraZeneca shares turned negative Wednesday after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.

Moderna’s coronavirus vaccine could be ready by the end of the year – if it’s proven safe.

Thousands of volunteers are taking part in the final phase of a coronavirus vaccine trial that is being watched closely by scientists around the world. News4’s Doreen Gentzler speaks with Brandon Benavides,a writer and producer for News4 and volunteer in the Moderna clinical trial.

Thousands of volunteers – including a member of the News4 family – are taking part in the third and final phase of a clinical coronavirus vaccine trial in hopes of saving lives and preventing countless others from getting sick.

While the symptoms were uncomfortable, and at times intense, they often went away after a day, sometimes less, some participants said.

Sen. Mark Warner says Republican opponent Daniel Gade can’t have it both ways in opposing ACA and protecting people with preexisting conditions. Gade said it’s offensive to say he would take away those protections. Both candidates said they would be willing to take a coronavirus vaccine if its safe.

The federal government is outlining a sweeping plan to make COVID-19 vaccines available for free to all Americans

Leading Maryland health officials and lawmakers are preparing for at least six to eight months before a coronavirus vaccine can be distributed in a best-case scenario

Centers for Disease Control and Prevention Director Robert Redfield testified on Wednesday that broad access to the COVID-19 vaccination likely won’t be available until “the second or third quarter” of 2021.

A drugmaker says it halted a coronavirus vaccine study because a woman who received the experimental shot developed severe neurological symptoms

AstraZeneca announced late Tuesday that it is pausing its crucial late-stage trial for its coronavirus vaccine candidate as a result of a patient illness. This comes a day after several companies signed a safety pledge to uphold the scientific standards that their experimental vaccines will be held against.

With the pharmaceutical industry fast-tracking a Covid-19 vaccine, some have questioned whether the public can trust that it is safe. But Former FDA Associate Commissioner Peter Pitts says people can rely on the scientific community to approve a vaccine that can be trusted.

The delivery of any future coronavirus vaccine requires “careful planning” with the air transport industry now in order to avoid “potentially severe” issues when it’s ready for global distribution, the International Air Transport Association (IATA) has warned.

AstraZeneca shares fell more than 6% in after-hours trading Tuesday after the company said its late-stage trial for a potential coronavirus vaccine had been put on hold due to safety concerns.

Public health officials are urging people to get a flu shot as we approach a potential “twindemic.” The move can protect your family and keep hospitals from seeing a surge in sick patients from COVID and the flu. News4’s Doreen Gentzler reports on the new guidance on when to get vaccinated.

In the more than eight months since the novel coronavirus emerged and then spread around the world, scientists across the globe have made rapid progress on developing a COVID-19 vaccine. As of Sept. 3, at least 176 vaccines are in the works, with nearly three dozen already in clinical trials, according to the World Health Organization. But until a vaccine is...

Could the U.S. really see a coronavirus vaccine before Election Day